Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
QingFeiYin is a traditional Chinese herbal formula used primarily for the treatment of acute lung injury (ALI) and respiratory conditions characterized by inflammation and heat in the lungs. It is composed of multiple herbs with actions that include clearing lung heat, transforming phlegm, stopping coughs, detoxifying the lungs, and supporting overall respiratory health. The formula contains active compounds that target pathways related to inflammation, apoptosis (cell death), oxidative stress as well as MAPK and PI3K-Akt signaling pathways. These mechanisms are believed to underlie its therapeutic effects in conditions such as ALI. The specific composition may vary slightly between manufacturers but typically includes ingredients like Armeniacae Semen (Xing Ren), Fritillaria Bulbus (Chuan Bei Mu), Glycyrrhiza Radix (Gan Cao), Eriobotrya japonica leaf (Pi Pa Ye), Morus alba root bark (Sang Bai Pi), Platycodon Radix (Jie Geng), Schisandra Fructus (Wu Wei Zi), Tangerine Peel (Ju Hong) among others[1][2][7]. It is widely available in granule or capsule form from various TCM suppliers.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on QingFeiYin.